1. Home
  2. PSN vs LEGN Comparison

PSN vs LEGN Comparison

Compare PSN & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSN
  • LEGN
  • Stock Information
  • Founded
  • PSN 1944
  • LEGN 2014
  • Country
  • PSN United States
  • LEGN United States
  • Employees
  • PSN N/A
  • LEGN N/A
  • Industry
  • PSN EDP Services
  • LEGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • PSN Technology
  • LEGN Health Care
  • Exchange
  • PSN Nasdaq
  • LEGN Nasdaq
  • Market Cap
  • PSN 7.8B
  • LEGN 7.0B
  • IPO Year
  • PSN 2019
  • LEGN 2020
  • Fundamental
  • Price
  • PSN $64.09
  • LEGN $31.78
  • Analyst Decision
  • PSN Buy
  • LEGN Strong Buy
  • Analyst Count
  • PSN 11
  • LEGN 13
  • Target Price
  • PSN $87.44
  • LEGN $79.42
  • AVG Volume (30 Days)
  • PSN 1.4M
  • LEGN 1.5M
  • Earning Date
  • PSN 04-30-2025
  • LEGN 05-13-2025
  • Dividend Yield
  • PSN N/A
  • LEGN N/A
  • EPS Growth
  • PSN 50.29
  • LEGN N/A
  • EPS
  • PSN 2.35
  • LEGN N/A
  • Revenue
  • PSN $6,769,260,000.00
  • LEGN $627,241,000.00
  • Revenue This Year
  • PSN $7.10
  • LEGN $65.96
  • Revenue Next Year
  • PSN $5.88
  • LEGN $52.55
  • P/E Ratio
  • PSN $27.20
  • LEGN N/A
  • Revenue Growth
  • PSN 16.61
  • LEGN 119.97
  • 52 Week Low
  • PSN $54.56
  • LEGN $29.27
  • 52 Week High
  • PSN $114.68
  • LEGN $60.87
  • Technical
  • Relative Strength Index (RSI)
  • PSN 50.74
  • LEGN 41.49
  • Support Level
  • PSN $60.09
  • LEGN $30.25
  • Resistance Level
  • PSN $64.62
  • LEGN $35.81
  • Average True Range (ATR)
  • PSN 2.16
  • LEGN 1.45
  • MACD
  • PSN -0.31
  • LEGN -0.18
  • Stochastic Oscillator
  • PSN 36.35
  • LEGN 27.58

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: